Atlas Trials

Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer

Clinical trial NCT02124681 · COMPLETED

Trial details

NCT number
NCT02124681
Sponsor
University of Pittsburgh
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Insulin Resistance
Start date
2014-04-01
Primary completion
2016-08-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.